{"nct_id":"NCT01181245","title":"A Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subjects With Locally Advanced or Metastatic Pancreatic Cancer","status":"COMPLETED","status_verified_date":"2014-08","start_date":"2008-12","start_date_type":null,"primary_completion_date":"2014-05","primary_completion_date_type":"ACTUAL","completion_date":"2014-06","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["FGEN"]}